載入中
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
前收盤價
US$8.30
−US$0.10 · -1.19%
盤中時間採用ET。市場資料可能有所延遲。
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
日內區間
目前US$8.30
52週區間
目前US$8.30
盤中時間採用ET。市場資料可能有所延遲。
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
日內區間
目前US$8.30
52週區間
目前US$8.30
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（EUR） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 2.57億 EUR | 2.67億 EUR | 2.56億 EUR | 2.32億 EUR | 2.05億 EUR |
| 銷貨成本 | 1.1億 EUR | 1.16億 EUR | 1.11億 EUR | 1.03億 EUR | 8727.8萬 EUR |
| 毛利 | 1.47億 EUR | 1.51億 EUR | 1.45億 EUR | 1.29億 EUR | 1.18億 EUR |
| 研究與開發 | 4427萬 EUR | 4440萬 EUR | 3809.8萬 EUR | 3756.8萬 EUR | 2689.1萬 EUR |
| 銷售、一般及管理費用 | 9631.7萬 EUR | 1.01億 EUR | 9489萬 EUR | 9301.7萬 EUR | 7758.7萬 EUR |
| 營業費用 | 1.42億 EUR | 1.41億 EUR | 1.4億 EUR | 1.32億 EUR | 1.06億 EUR |
| 利息收入 | 381.14萬 EUR | 425.2萬 EUR | 445萬 EUR | 139.99萬 EUR | 77.77萬 EUR |
| 利息支出 | 539.44萬 EUR | 165萬 EUR | 208.9萬 EUR | 291.65萬 EUR | 336.04萬 EUR |
| 折舊和攤銷 | 2084.84萬 EUR | 2176.1萬 EUR | 2156.9萬 EUR | 2256.8萬 EUR | 2054.9萬 EUR |
| 營業利益 | 494.39萬 EUR | 943.2萬 EUR | 561.9萬 EUR | −287.2萬 EUR | 1221.7萬 EUR |
| 淨利 | 741.34萬 EUR | 1343.6萬 EUR | 672.2萬 EUR | −212.3萬 EUR | 1315.4萬 EUR |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$10.00
上漲空間 20.48%報告持有此股票曝險的交易所交易基金。
The 3D Printing ETFPRNT287.38萬4.64%5870萬 USD0.66%US$25.50+0.80%
Pacer BlueStar Engineering the Future ETFBULD32.88萬2.21%1487.87萬 USD0.49%US$37.238+0.94%
ActivePassive International Equity ETFAPIE25.47萬0.02%11.41億 USD0.45%US$38.56+0.65%
State Street SPDR S&P International Small Cap ETFGWX21.64萬0.02%9.08億 USD0.40%US$45.56+0.93%
State Street SPDR Portfolio Developed World ex-US ETFSPDW8.34萬0.00%404.62億 USD0.03%US$49.98+0.64%The 3D Printing ETFPRNTPacer BlueStar Engineering the Future ETFBULDActivePassive International Equity ETFAPIEState Street SPDR S&P International Small Cap ETFGWXState Street SPDR Portfolio Developed World ex-US ETFSPDWAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
